NSEPress Release2d ago · 4 Nov 2026, 01:58 pm

Press Release

Jyothy Labs Limited · JYOTHYLAB

✦ AI SummaryResults

Jyothy Labs Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with revenue growth of 3.3% and 3.1% respectively, despite input cost headwinds.

Analysis Scores

Earnings Impact5/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Jyothy Labs Limited has informed the Exchange regarding a press release dated November 04, 2026, titled "Press Release".

Attachments (1)

📄

JYOTHYLAB_04112026134840_SE_IntimationPress_Release.pdf

pdf

Download →
View document text
November 4, 2026 BSE Limited N ational Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra – Kurla Complex, Dalal Street, Mumbai – 400 023 Bandra (E), Mumbai – 400 051 BSE Code: 532926 Scrip Code: JYOTHYLAB Dear Sir/ Madam, Sub: Press Release Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find attached herewith Press Release by the Company in respect of its performance during the quarter and half-year ended September 30, 2026. Kindly take the above on your record and disseminate the same for the information of investors. Thanking you, Yours faithfully, For Jyothy Labs Limited Shreyas Trivedi Head – Legal & Company Secretary Encl.: as above Jyothy Labs Limited CIN: L24240MH1992PLC128651 ‘Ujala House’, Ramkrishna Mandir Road, Kondivita, Andheri (East), Mumbai 400059. Tel: +91 022-6689 2800 | Fax: +91 022-6689 2805 info@jyothy.com | www.jyothylabs.com • Jyothy labs PRESS RELEASE RESULTS FOR THE QUARTER AND HALF YEAR ENDED SEPTEMBER 30, 2026 Jyothy Labs maintains growth momentum in Q2 FY27 despite input cost headwinds, prioritizes progressive margin recovery Mumbai, November 4, 2026: Jyothy Labs Limited, one of India's leading fast-moving consumer goods (FMCG) companies, today announced its unaudited financial results for the quarter and half year ended September 30, 2026. The Company's underlying business continued to demonstrate healthy growth, supported by strong performance in Fabric Care, sustained momentum in the Exo franchise, new product launches and improving contributions from emerging trade channels. Excluding the Pril and Fa businesses, revenue grew by 12.4% in value and 8.1 % in volume during the quarter, reflecting the strength of its core portfolio. The broader FMCG operating environment remained challenging, with uneven demand recovery and unprecedented inflation in crude derivatives, palm oil, chemicals and packaging materials. While rural consumption continued to outperform urban markets, signs of gradual urban recovery were encouraging. However, rising input costs and continued pressure on consumer affordability weighed on industry profitability. Despite healthy underlying growth, the Company's profitability was significantly impacted by elevated commodity costs and the consumption of higher cost inventories. Management remains focused on progressively restoring margins through calibrated pricing, procurement efficiencies, value engineering, improved product mix and cost discipline, while protecting consumer demand and brand competitiveness. The Company continues to strengthen its core brands, accelerate new product launches and expand distribution across traditional and emerging channels. FINANCIAL HIGHLIGHTS-Q2 FY27 (YoY) • Revenue from Operations at <760 crore, representing 3.3% reported value growth. • Excluding Pril and Fa, revenue growth of 12.4% in value and 8.1 % in volume. • Operating EBITDA at <19.2 crore, with an EBITDA margin of2.5%, reflecting significant input cost inflation. • Profit After Tax at <10.6 crore. FINANCIAL HIGHLIGHTS - Hl FY27 (Yo Y) • Revenue from Operations at <1,533 crore, representing 3.1% reported value growth. • Excluding Pril and Fa, revenue growth of 10.2% in value and 6.2% in volume. • Operating EBITDA at <83.9 crore, with an EBITDA margin of 5.5%. • Profit After Tax at <58.2 crore. SEGMENT PERFORMANCE: FABRIC CARE - Fabric Whitener, Fabric Enhancer, Fabric Conditioner, Bar Soap, Detergent Powder, Liquid Detergent and Laundry Service Fabric Care maintained its strong growth momentum, delivering 10.4% value growth and 6.4% volume growth during the quarter. Growth was broad-based across the portfolio, led by continued momentum in liquid Jyothy Labs Limited CIN: L24240MH1992PLC128651 'Ujala House', Ramkrishna Mandir Road, Kondivita, Andheri {East), Mumbai 400 059. Tel: +91 022-6689 2800 info@jyothy.com I www.jyothylabs.com detergents and supported by healthy performance in detergent powders and bars. Liquid detergents continued to lead category growth, supported by sustained consumer adoption and strong performance across Henko, Ujala, Morelight and Mr. White. Detergent powders and bars maintained healthy momentum, while Ujala Young and Fresh fabric conditioner continued to gain traction. The Company remains focused on strengthening its position in core laundry formats through innovation, distribution expansion and sustained brand investments. HOME CARE - Dish Wash Bar, Liquid, Gel, Powder and Scrubbers, Mosquito Repellent Coil, Liquid Vaporiser, Racquet, Aerosol, Agarbatti, Incense Sticks The Home Care segment delivered healthy underlying growth of 15.3% in value and 13.1% in volume, excluding Pril sales. The Exo franchise continued to demonstrate strong momentum, supported by expanding distribution. The recently launched bio enzyme-based Exo Dishwash Liquid, endorsed by Yami Gautam and Keerthy Suresh, has received an encouraging consumer response across markets and channels. The Company remains focused on further scaling the Exo portfolio to strengthen its presence in the Dishwash category. In Household Insecticides, the Company expanded its Maxo portfolio with the introduction ofMaxo Agarbatti, featuring a government approved mosquito control formulation. The launch addresses consumer demand for regulated mosquito repellent solutions and strengthens the Company's presence across key product formats. The strategic focus remains on scaling newer formats, improving product mix and progressively restoring profitability in Household Insecticides. PERSONAL CARE-Body Soap, Hand Wash and Toothpaste. Personal Care recorded 11.2% value growth during the quarter, while volumes declined marginally reflecting the impact of pricing actions and a favourable comparative base following last year's GST transition. The Margo franchise continued to benefit from focused brand investments and improved market visibility. The Company introduced Margo Gentle, a glycerine bathing soap, in Argan Oil and Moringa Oil variants in select markets, expanding the brand's presence in differentiated personal cleansing formats. Commenting on the financial performance of Q2 FY27, Ms. M. R. Jyothy, Chairperson and Managing Director, Jyothy Labs Limited said: "Q2 demonstrated the strength of our underlying business, delivering 12.4% value growth and 8.1% volume growth, excluding Pril and Fa, supported by healthy momentum in Fabric Care, Exo and new product launches. However, unprecedented inflation in raw material and packaging costs significantly impacted profitability, despite our pricing and cost efficiency measures. While near term margin pressures may persist, we remain confident of sustaining double digit underlying value growth in the coming quarters. Our priorities are to accelerate new launches, strengthen core brands and progressively restore margins through calibrated pricing, operational efficiencies and disciplined cost management. Our strong balance sheet provides us the financial flexibility to pursue both organic and selective inorganic growth opportunities, while maintaining discipline in capital allocation and a clear focus on long term shareholder value creation. " About Jyothy Labs Limited: Founded in 1983, Jyothy Labs Limited (JLL) has grown from a single-brand company with its flagship brand Ujala to a multi-brand FMCG listed on both BSE and NSE. Today, Jyothy Labs is a household name across India, producing and marketing a diverse range of products in Fabric Care, Home Care, and Personal Care Segments. The company's portfolio includes popular brands such as Ujala, Exo, Henka, Margo, Maxo, Mr. White, Morelight, Neem toothpaste, Jovia, Dr. Wool and Maya, each with a strong presence in its respective category and reco · · and consumer trust. For more information, please contact: -Jyothy Labs Limited; E-mail: pawan.agarw